ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU)

Intergroupe Francophone de Cancerologie Thoracique · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
met alterations, non small cell lung cancer, metex14 mutations, expanded access program, capmatinib, met tkis, ifct, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 889546
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.